Our partners EATG (European AIDS Treatment Group) is a European network of nationally-based volunteer activists comprising of more than 110 members from 40 countries in Europe. Our members are representatives of different communities affected by HIV/AIDS in Europe. The nature of the EATG implies that it has members all over Europe and sometimes even beyond. There are two kinds of membership:
- Supportive Membership, without voting right
- Ordinary Membership, with voting right, usually granted after 1 year
We are working with them and they have published a notice about «study finds durable drug-free control of HIV is uncommon when treatment is interrupted».
By strengthening the immune system and reducing the amount of HIV in the blood below the threshold of detection—a level commonly called “undetectable”—potent combination anti-HIV therapy (commonly called ART) can have several benefits, including the following:
- It can tremendously reduce the risk of developing AIDS-related infections.
- It can increase the life expectancy of some people to near normal.
- It can significantly reduce the risk of sexually spreading HIV.
However, ART does have some drawbacks, including the following:
- It cannot cure HIV infection.
- It needs to be taken at least once daily for life.
- Some regimens can have side effects.
more info and page: Notice